Stockreport

ProMIS Neurosciences Showcases Preclinical Data on Platform Derived Vaccines for Neurodegenerative Diseases at the American Academy of Neurology 2025 Annual Meeting [Yahoo! Finance]

ProMIS Neurosciences Inc. - Common Shares  (PMN) 
PDF biotechnology company focused on the generation and development of antibody therapeutics and vaccines targeting toxic misfolded proteins in neurodegenerative diseases su [Read more]